Compare · MDLN vs SGHT
MDLN vs SGHT
Side-by-side comparison of Medline Inc. (MDLN) and Sight Sciences Inc. (SGHT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and SGHT operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $58.79B, about 242.8x SGHT ($242.1M).
- Over the past year, MDLN is up 9.8% and SGHT is up 46.1% - SGHT leads by 36.2 points.
- SGHT has been more active in the news (8 items in the past 4 weeks vs 6 for MDLN).
- MDLN has more recent analyst coverage (25 ratings vs 19 for SGHT).
- Company
- Medline Inc.
- Sight Sciences Inc.
- Price
- $44.76+0.65%
- $4.44+8.82%
- Market cap
- $58.79B
- $242.1M
- 1M return
- +1.69%
- +21.15%
- 1Y return
- +9.84%
- +46.05%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2021
- News (4w)
- 6
- 8
- Recent ratings
- 25
- 19
Sight Sciences Inc.
Sight Sciences, Inc., an ophthalmic medical device company, engages the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology, for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Latest MDLN
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- SEC Form DEFA14A filed by Medline Inc.
- SEC Form DEF 14A filed by Medline Inc.
- Medline announces first-in-healthcare AI robotics partnership with Symbotic
- Medline to report first quarter 2026 results on May 6, 2026
- Medline launches custom product fulfillment technology called Pick Pack Pro™
- Medline recognizes manufacturing facilities with Golden Cone Safety Award
- Medline receives HIRC Member Choice Awards for supply chain achievement and renews Transparency Badge distinction
- Director Healy Patrick J acquired 577,510 shares, increasing direct ownership by 73% to 1,208,159 units (SEC Form 4)
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,058,524,148 worth of shares (26,131,237 units at $40.51) and disposed of 2,088,086 shares (SEC Form 4)
Latest SGHT
- Sight Sciences to Present at Two Upcoming Investor Conferences
- Sight Sciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Sight Sciences Announces the Release of its Sustainability Report
- SEC Form DEFA14A filed by Sight Sciences Inc.
- SEC Form DEF 14A filed by Sight Sciences Inc.
- Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026
- SEC Form 4 filed by Rodberg James
- SEC Form 4 filed by Hayden Jeremy B.
- SEC Form 4 filed by Bauerlein Alison
- SEC Form 4 filed by Badawi David